Article
San Francisco - Inamed Corp. received approval from the U.S. Food and Drug Administration to compete against what it considers a formidable foe - its own ZyDerm and ZyPlast products.
Salicylic Acid and Piroctone Olamine Combination Treatment is Highly Successful for Scalp SD Treatment
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Expanding NP and PA Opportunities in Dermatology Practice
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Success Factors for Employed Dermatologists
Link Between AA and Inflammatory Diseases